CVD-grown MXene-CNT nanocomposite-assisted electrochemical immunosensors for label-free and ultra-sensitive monitoring of thyroid-stimulating hormone in artificial serum.
{"title":"CVD-grown MXene-CNT nanocomposite-assisted electrochemical immunosensors for label-free and ultra-sensitive monitoring of thyroid-stimulating hormone in artificial serum.","authors":"Vijayaraj Kathiresan, Sakda Jampasa, Thirumal Vediyappan, Dharuman Venkataraman, Viwat Vchirawongkwin, Orawon Chailapakul","doi":"10.1039/d5tb01632k","DOIUrl":null,"url":null,"abstract":"<p><p>Thyroid-stimulating hormone (TSH) is a critical clinical biomarker for evaluating thyroid function and is essential in diagnosing and monitoring related hormonal disorders. However, the development of point-of-care diagnostic devices for the early detection of TSH-associated diseases remains challenging, particularly due to constraints in measurement methodologies in resource-limited settings. This research describes an effective electrochemical immunosensor developed from a novel seamless three-dimensional (3D) Ti<sub>3</sub>C<sub>2</sub>T<sub><i>x</i></sub> (MXene)-carbon nanotube (CNT) nanocomposite, specifically engineered for the ultrasensitive and label-free detection of low TSH concentrations. The MXene-CNT nanocomposite was synthesized using the chemical vapor deposition (CVD) method, and its physical characteristics and electrochemical sensing capabilities were examined. The unique synergetic properties of the MXene-CNT nanocomposite enhance antibody immobilization, expand the sensor's surface area (0.119 cm<sup>2</sup>), provide additional binding sites, and improve electrical conductivity, leading to superior sensitivity and stability of the biosensor. With a label-free format, the redox mediator signal decreased significantly in response to varying concentrations of TSH, attributable to the insulating immunocomplexes formed between anti-TSH and TSH on the MXene-CNT-modified disposable electrode. The method achieved a dynamic linear range of 0.1-10 000 pg mL<sup>-1</sup>, with a detection limit of 0.03 pg mL<sup>-1</sup>, showcasing high selectivity against interferents. Importantly, this study presents the first successful electrochemical detection of TSH in artificial serum using the CVD-grown MXene-CNT nanocomposite immunosensor, underscoring its potential for real-sample analysis in complex biological environments. The current study opens new avenues for leveraging the CVD-grown MXene-CNT nanocomposites in designing and developing molecular diagnosis-based electrochemical and related biosensors.</p>","PeriodicalId":94089,"journal":{"name":"Journal of materials chemistry. B","volume":" ","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of materials chemistry. B","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1039/d5tb01632k","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Thyroid-stimulating hormone (TSH) is a critical clinical biomarker for evaluating thyroid function and is essential in diagnosing and monitoring related hormonal disorders. However, the development of point-of-care diagnostic devices for the early detection of TSH-associated diseases remains challenging, particularly due to constraints in measurement methodologies in resource-limited settings. This research describes an effective electrochemical immunosensor developed from a novel seamless three-dimensional (3D) Ti3C2Tx (MXene)-carbon nanotube (CNT) nanocomposite, specifically engineered for the ultrasensitive and label-free detection of low TSH concentrations. The MXene-CNT nanocomposite was synthesized using the chemical vapor deposition (CVD) method, and its physical characteristics and electrochemical sensing capabilities were examined. The unique synergetic properties of the MXene-CNT nanocomposite enhance antibody immobilization, expand the sensor's surface area (0.119 cm2), provide additional binding sites, and improve electrical conductivity, leading to superior sensitivity and stability of the biosensor. With a label-free format, the redox mediator signal decreased significantly in response to varying concentrations of TSH, attributable to the insulating immunocomplexes formed between anti-TSH and TSH on the MXene-CNT-modified disposable electrode. The method achieved a dynamic linear range of 0.1-10 000 pg mL-1, with a detection limit of 0.03 pg mL-1, showcasing high selectivity against interferents. Importantly, this study presents the first successful electrochemical detection of TSH in artificial serum using the CVD-grown MXene-CNT nanocomposite immunosensor, underscoring its potential for real-sample analysis in complex biological environments. The current study opens new avenues for leveraging the CVD-grown MXene-CNT nanocomposites in designing and developing molecular diagnosis-based electrochemical and related biosensors.